BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 9015034)

  • 1. Female alloimmunization with antibodies known to cause hemolytic disease.
    Geifman-Holtzman O; Wojtowycz M; Kosmas E; Artal R
    Obstet Gynecol; 1997 Feb; 89(2):272-5. PubMed ID: 9015034
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of pregnancies complicated by anti-E alloimmunization.
    Joy SD; Rossi KQ; Krugh D; O'Shaughnessy RW
    Obstet Gynecol; 2005 Jan; 105(1):24-8. PubMed ID: 15625137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fetal anemia due to non-Rhesus-D red-cell alloimmunization.
    Moise KJ
    Semin Fetal Neonatal Med; 2008 Aug; 13(4):207-14. PubMed ID: 18396474
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blood transfusion and alloimmunization in patients with thalassemia: multicenter study.
    Azarkeivan A; Ansari S; Ahmadi MH; Hajibeigy B; Maghsudlu M; Nasizadeh S; Shaigan M; Toolabi A; Salahmand M
    Pediatr Hematol Oncol; 2011 Sep; 28(6):479-85. PubMed ID: 21854216
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Incidence of erythrocyte alloimmunization in pregnant women in olomouc region].
    Holusková I; Lubušký M; Studničková M; Procházka M
    Ceska Gynekol; 2013 Jan; 78(1):56-61. PubMed ID: 23607383
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Red blood cell antibodies in pregnancy and their clinical consequences: synergistic effects of multiple specificities.
    Nordvall M; Dziegiel M; Hegaard HK; Bidstrup M; Jonsbo F; Christensen B; Hedegaard M
    Transfusion; 2009 Oct; 49(10):2070-5. PubMed ID: 19497053
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreased fetal erythropoiesis and hemolysis in Kell hemolytic anemia.
    Weiner CP; Widness JA
    Am J Obstet Gynecol; 1996 Feb; 174(2):547-51. PubMed ID: 8623782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of screening for red cell antibodies, other than anti-D, to detect hemolytic disease of the fetus and newborn: a population study in the Netherlands.
    Koelewijn JM; Vrijkotte TG; van der Schoot CE; Bonsel GJ; de Haas M
    Transfusion; 2008 May; 48(5):941-52. PubMed ID: 18248570
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Severe anemia due to Kell alloimmunization.
    Giannacopoulou CH; Relakis K; Kalmanti M
    Haematologia (Budap); 1997; 28(3):173-5. PubMed ID: 9283918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The risk assessment study for hemolytic disease of the fetus and newborn in a University Hospital in Turkey.
    Altuntas N; Yenicesu I; Himmetoglu O; Kulali F; Kazanci E; Unal S; Aktas S; Hirfanoglu I; Onal E; Turkyilmaz C; Ergenekon E; Koc E; Atalay Y
    Transfus Apher Sci; 2013 Jun; 48(3):377-80. PubMed ID: 23619329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of maternal red cell alloimmunisation: a population study from Queensland, Australia.
    Pal M; Williams B
    Pathology; 2015 Feb; 47(2):151-5. PubMed ID: 25551305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic factors and management in pregnancies complicated with severe kell alloimmunization: experiences of the last 13 years.
    Babinszki A; Lapinski RH; Berkowitz RL
    Am J Perinatol; 1998; 15(12):695-701. PubMed ID: 10333397
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current clinical management of anti-Kell alloimmunization in pregnancy.
    Santiago JC; Ramos-Corpas D; Oyonarte S; Montoya F
    Eur J Obstet Gynecol Reprod Biol; 2008 Feb; 136(2):151-4. PubMed ID: 17481801
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of anti-Jka alloimmunization.
    Franco A; Rossi K; Krugh D; O'Shaughnessy R
    J Reprod Med; 2009 Mar; 54(3):121-5. PubMed ID: 19370894
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alloimmunizations following blood transfusions.
    Hundrić-Haspl Z; Juraković-Loncar N; Grgicević D; Balija M
    Acta Med Croatica; 1994; 48(4-5):193-7. PubMed ID: 7534524
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alloimmunization to red blood cell antigens after universal leucodepletion. A regional multicentre retrospective study.
    Schonewille H; Brand A
    Br J Haematol; 2005 Apr; 129(1):151-6. PubMed ID: 15801967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Haemolytic disease of the newborn--from a mother with anti-Kell, anti-E and anti-Vel anti-erythrocyte alloantibodies].
    Vućinović M; Jadrić H; Karelović D; Roje D; Haspl-Hundrić Z; Hrgović Z; Vućinović Z
    Z Geburtshilfe Neonatol; 2004 Oct; 208(5):197-202. PubMed ID: 15508054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Red blood cell alloimmunization in sickle cell disease: the influence of racial and antigenic pattern differences between donors and recipients in Brazil.
    Moreira Júnior G; Bordin JO; Kuroda A; Kerbauy J
    Am J Hematol; 1996 Jul; 52(3):197-200. PubMed ID: 8756087
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alloimmunization to red cells in thalassemics: emerging problem and future strategies.
    Gupta R; Singh DK; Singh B; Rusia U
    Transfus Apher Sci; 2011 Oct; 45(2):167-70. PubMed ID: 21856231
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk of maternal alloimmunization in Southern Pakistan - a study in a cohort of 1000 pregnant women.
    Karim F; Moiz B; Kamran N
    Transfus Apher Sci; 2015 Feb; 52(1):99-102. PubMed ID: 25532481
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.